Literature DB >> 18474362

Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure.

Menahem B Doura1, Allison B Gold, Ashleigh B Keller, David C Perry.   

Abstract

Adolescence is a time of significant brain development, and exposure to nicotine during this period is associated with higher subsequent rates of dependence. Chronic nicotine exposure alters expression of nicotinic acetylcholine receptors (nAChRs), changing the pattern of nicotine responsiveness. We used quantitative autoradiography to measure three major subtypes of nAChRs after chronic nicotine exposure by osmotic minipump in adult and periadolescent rats. Comparison of control animals at the two different ages revealed that periadolescents express consistently greater numbers of alpha4beta2* nAChRs compared to the same brain regions of adults. Similar but less pronounced increases in alpha7 nAChRs were found in control periadolescent rats compared to adults. Binding of [(125)I]alpha-conotoxin MII (largely to alpha6* nAChRs) did not systematically differ between adults and periadolescents. The response to chronic nicotine exposure also differed by age. Up-regulation of alpha4beta2* nAChRs was prominent and widespread in adult animals; in periadolescents, alpha4beta2* up-regulation also occurred, but in fewer regions and to a lesser extent. A similar pattern of response was seen with alpha7 receptors: adults were more responsive than periadolescents to nicotine-induced up-regulation. In adult animals, chronic nicotine exposure did not cause up-regulation of alpha6* nAChRs; binding was down-regulated in three regions. Unlike the other subtypes, the response of alpha6* nAChRs to chronic nicotine was greater in periadolescents, with more regions showing greater down-regulation compared to adults. These differences in receptor expression and regulation between age groups are likely to be important given the unique vulnerability of adolescents to nicotine-induced behavioral changes and susceptibility to drug abuse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474362      PMCID: PMC2493527          DOI: 10.1016/j.brainres.2008.03.056

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  Periadolescent nicotine exposure reduces cocaine reward in adult mice.

Authors:  B M Kelley; L D Middaugh
Journal:  J Addict Dis       Date:  1999

2.  Impact of adolescent nicotine exposure on adenylyl cyclase-mediated cell signaling: enzyme induction, neurotransmitter-specific effects, regional selectivities, and the role of withdrawal.

Authors:  Yael Abreu-Villaça; Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res       Date:  2003-10-24       Impact factor: 3.252

3.  Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats.

Authors:  Walter Adriani; Sabine Spijker; Véronique Deroche-Gamonet; Giovanni Laviola; Michel Le Moal; August B Smit; Pier Vincenzo Piazza
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

Review 4.  Adolescent brain development and animal models.

Authors:  Linda Patia Spear
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

5.  Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats.

Authors:  Stephanie L Collins; Sari Izenwasser
Journal:  Neuropharmacology       Date:  2004-03       Impact factor: 5.250

6.  Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.

Authors:  Henry N Nguyen; Bruce A Rasmussen; David C Perry
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

7.  Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography.

Authors:  Henry N Nguyen; Bruce A Rasmussen; David C Perry
Journal:  J Pharmacol Exp Ther       Date:  2003-10-14       Impact factor: 4.030

8.  Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.

Authors:  Nicolas Champtiaux; Cecilia Gotti; Matilde Cordero-Erausquin; Denis J David; Cédric Przybylski; Clément Léna; Francesco Clementi; Milena Moretti; Francesco M Rossi; Nicolas Le Novère; J Michael McIntosh; Alain M Gardier; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

9.  Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.

Authors:  Martha I Dávila-García; John L Musachio; Kenneth J Kellar
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

10.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

View more
  66 in total

1.  Varenicline modulates ethanol and saccharin consumption in adolescent male and female C57BL/6J mice.

Authors:  Helen M Kamens; Constanza Silva; Colette Peck; Carley N Miller
Journal:  Brain Res Bull       Date:  2017-08-01       Impact factor: 4.077

2.  Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex.

Authors:  Danielle S Counotte; Natalia A Goriounova; Milena Moretti; Marek T Smoluch; Hubertus Irth; Francesco Clementi; Anton N M Schoffelmeer; Huibert D Mansvelder; August B Smit; Cecilia Gotti; Sabine Spijker
Journal:  FASEB J       Date:  2012-02-03       Impact factor: 5.191

Review 3.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

4.  Regulation of α4β2α5 nicotinic acetylcholinergic receptors in rat cerebral cortex in early and late adolescence: Sex differences in response to chronic nicotine.

Authors:  Bethany G Hoegberg; Ermelinda Lomazzo; Norman H Lee; David C Perry
Journal:  Neuropharmacology       Date:  2015-08-10       Impact factor: 5.250

Review 5.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

6.  A new radioligand binding assay to measure the concentration of drugs in rodent brain ex vivo.

Authors:  G Patrick Hussmann; Kenneth J Kellar
Journal:  J Pharmacol Exp Ther       Date:  2012-08-16       Impact factor: 4.030

7.  Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking.

Authors:  Luis M Carcoba; James E Orfila; Luis A Natividad; Oscar V Torres; Joseph A Pipkin; Patrick L Ferree; Eddie Castañeda; Donald E Moss; Laura E O'Dell
Journal:  Dev Neurosci       Date:  2014-05-15       Impact factor: 2.984

Review 8.  Unique, long-term effects of nicotine on adolescent brain.

Authors:  Frances M Leslie
Journal:  Pharmacol Biochem Behav       Date:  2020-07-30       Impact factor: 3.533

9.  Long-term effects of chronic nicotine on emotional and cognitive behaviors and hippocampus cell morphology in mice: comparisons of adult and adolescent nicotine exposure.

Authors:  Erica D Holliday; Paul Nucero; Munir G Kutlu; Chicora Oliver; Krista L Connelly; Thomas J Gould; Ellen M Unterwald
Journal:  Eur J Neurosci       Date:  2016-10-19       Impact factor: 3.386

10.  Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal.

Authors:  Luis A Natividad; Matthew W Buczynski; Loren H Parsons; Oscar V Torres; Laura E O'Dell
Journal:  J Neurochem       Date:  2012-10-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.